Towa Financial Statements From 2010 to 2025
| TWAPFDelisted Stock | USD 16.83 0.00 0.00% |
Check Towa Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Towa Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Towa financial statements analysis is a perfect complement when working with Towa Pharmaceutical Valuation or Volatility modules.
Towa |
Towa Pharmaceutical Co Company Return On Equity Analysis
Towa Pharmaceutical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Towa Pharmaceutical Return On Equity | 14.4 |
Most of Towa Pharmaceutical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Towa Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Towa Pharmaceutical Co has a Return On Equity of 14.4. This is 160.08% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably lower than that of the firm.
Towa Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Towa Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Towa Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Towa Pharmaceutical competition to find correlations between indicators driving Towa Pharmaceutical's intrinsic value. More Info.Towa Pharmaceutical Co is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Towa Pharmaceutical Co is roughly 2.63 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Towa Pharmaceutical's earnings, one of the primary drivers of an investment's value.About Towa Pharmaceutical Financial Statements
Towa Pharmaceutical stakeholders use historical fundamental indicators, such as Towa Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Towa Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Towa Pharmaceutical's assets and liabilities are reflected in the revenues and expenses on Towa Pharmaceutical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Towa Pharmaceutical Co. Please read more on our technical analysis and fundamental analysis pages.
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan. Towa Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3456 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Towa Pink Sheet
If you are still planning to invest in Towa Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Towa Pharmaceutical's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |